Keywords: cancer, research, tech, licenses, antibodies, peptech, uk

Cancer Research Tech licenses antibodies to Peptech

Article | 07 May 2007

Print This

The UK's Cancer Research Technology says it has licensed rights to a panel of cancer therapeutic antibodies to Peptech, granting ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in